Abstract
Background
Decolonization with topical antibiotics is necessary to control outbreaks of multidrug-resistant bacterial infection in the Neonatal Intensive Care Unit (NICU), but can trigger bacterial resistance. The objective of this study was to determine whether skin-to-skin contact of newborns colonized with Methicillin-Oxacillin Resistant Staphylococcus aureus or Methicillin-Oxacillin-Resistant Coagulase-Negative Staphylococcus aureus (MRSA/MRSE) with their mothers could be an effective alternative to promote bacterial decolonization of newborns’ nostrils.
Methods
We performed a randomized clinical trial with 102 newborns admitted to the NICU in three hospitals in São Luís, Brazil. Inclusion criteria were birth weight of 1300 to 1800 g, more than 4 days of hospitalization, newborns with positive nostril cultures for MRSA and/or multidrug-resistant coagulase-negative Staphylococcus and mothers not colonized by these bacteria. We used a random number algorithm for randomization. Allocation was performed using sealed opaque envelopes. Skin-to-skin contact was given twice a day for 60 minutes for seven consecutive days. The control group received routine care without skin-to-skin contact. There was no masking of newborn’s mothers or researchers but the individuals who carried out bacterial cultures and assessed results were kept blind to group allocation. The primary outcome was colonization status of newborns’ nostrils after 7 days of intervention. The directional hypothesis was that more newborns who receive skin-to-skin holding 2 hours/day for 7 days than newborns who receive normal care will be decolonized.
Results
Decolonization of MRSA/MRSE was greater in the intervention group (Risk Ratio = 2.27; 95% CI 1.27-4.07, p-value = 0.003). Number Needed to Treat (NNT) was 4.0 (95% CI 2.2 – 9.4). After adjustment for the possible confounding effects of small for gestational age birth, antibiotic use, need for resuscitation, sex and cesarean delivery, skin-to-skin contact remained strongly associated with decolonization of newborns’ nostrils from MRSA/MRSE bacteria (p = 0.007). There was no need to interrupt the trial for safety reasons.
Conclusion
Skin-to-skin contact might be an effective and safe method for promoting decolonization of newborns’ nostrils colonized by MRSA/MRSE.
Trial Registration
The study was registered with ClinicalTrials.gov (NCT01498133, November 21, 2011).
Keywords: Skin-to-skin contact, Decolonization, MRSA/MRSE
Background
Staphylococcus resistant to methicillin-oxacillin is one of the most frequent pathogens colonizing newborns (NB) admitted to Neonatal Intensive Care Units (NICU) [1]. They are identified as being primarily responsible for outbreaks of nosocomial infection especially in situations of overcrowding and understaffing [2,3]. Mupirocin promotes decolonization of these bacteria, but does not prevent outbreaks of infection and can trigger bacterial resistance [4-6].
Studies suggest that the presence of nonpathogenic bacteria can inhibit MRSA growth. Uehara et al. [7] showed that colonization by MRSA could be inhibited by the presence of methicillin non-resistant bacteria (Streptococcus viridans group) in the oral cavity of newborns admitted to neonatal units. Shimizu et al. [8] also showed the same effect on preterm infants admitted to the NICU of Nagano Children's Hospital.
Other studies have indicated the possibility of transmission of MRSA from mother to newborn through skin-to-skin contact. In 2003, Kawada et al. postulated that transmission of MRSA from mother to infant could occur through breastfeeding [9]. Sakaki et al. [10] found an association between skin-to-skin contact and newborn MRSA infection.
Several studies have also shown that certain bacteria of the normal flora of human skin and mucous membranes have the ability to take the place of multiresistant bacteria that are already installed, through a competitive mechanism termed bacterial interference [11,12]. This mechanism has been used to promote healing of infections by multiresistant bacteria mainly in the fields of urology and otorhinolaryngology [13,14]. It is also possible that this mechanism could be responsible for the ability of the Kangaroo Mother Care to reduce infection rates of newborns undergoing this method, as demonstrated by Lawn et al. in 2010 [15] and Conde-Agudelo, et al., 2011, in a Cochrane database meta-analysis [16].
Kangaroo mother care (KMC) is an effective and safe alternative to conventional neonatal care in low birthweight (LBW) infants that was found to reduce mortality at discharge or 40–41 weeks’ postmenstrual age and at latest follow up, severe infection/sepsis, nosocomial infection/sepsis, hypothermia, severe illness, lower respiratory tract disease, and length of hospital stay. The major component of KMC is skin-to-skin contact (SSC) between a mother and her newborn. Recently Lawn et al. [15] demonstrated that Kangaroo mother care is effective in preventing neonatal deaths due to preterm birth complications [17].
As literature points to an association between KMC and reduction of infections in preterm newborns, we tested the hypothesis of whether skin-to-skin contact between newborns colonized by MRSA/MRSE and their mothers is associated with decolonization of newborns’ nostrils.
Methods
Trial design and settings
We performed a controlled parallel randomized and single-blind clinical trial, conducted at the NICU of three public maternity hospitals in São Luís, northeastern Brazil: Hospital of the Federal University of Maranhão (HUMI), Marly Sarney Maternity Hospital (MMS) and Benedito Leite Maternity Hospital (MBL).
Sample
A target sample of 100 patients (including possible losses to follow-up) was calculated considering a 30% difference in the percentage of decolonization between the intervention and control groups, with 80% power and 5% probability of type I error, assuming that percentage of decolonization in the control group is 20% and setting the ratio between groups at 1:1.
Participants
Eligible subjects were singleton neonates, born at the three institutions of the study, weighing 1300 to 1800 g and clinically stable. They had been hospitalized for more than 4 days and their nostrils were colonized by Staphylococcus aureus or coagulase-negative Staphylococcus resistant to methicillin-oxacillin. Mothers were not colonized in their nostrils by these bacteria and did not present skin diseases.
Included infants and hospital participation
A total of 247 (21 from HUMI; 180 from MMS; 46 from MBL) dyads (mother and newborn) were assessed for eligibility from April 2008 to December 2010. The different number of patients assessed for eligibility in the three study hospitals was due to differences in size and number of hospitalizations in these units. Moreover, in the HUMI unit, data collection had to be discontinued because the skin-to-skin position was instituted as routine care, making randomization impossible.
A total of 102 dyads were found to be eligible for the study.
Excluded infants
The remaining 145 newborns were not included in the study, 121 because they were not colonized with MRSA/MRSE and/or because their mothers were colonized with MRSA/MRSE at their first nostrils’ culture. One mother refused to participate and 23 did not participate for other reasons (Figure 1).
Figure 1.
Selection, allocation, intervention, monitoring and analysis of the patients enrolled in the study. São Luís, Brazil, 2008–2010.
We did not include infants below 1300 g because they were often subjected to routine umbilical catheterization. Infants over 1800 g were excluded because they remained, in general, less than four days in the NICU. Those who underwent surgery for congenital problems, ostomy and urethral catheter drainage were not included as well.
Allocation
For allocation of participants, a computer-generated random number list was used. The allocation sequence was concealed by using sealed opaque black envelopes. After identification of each eligible dyad the chief researcher in the presence of the mother in the NICU opened an envelope. Groups were then formed (intervention group, n = 53; control n = 49).
Mothers and researchers were aware of group allocation (intervention or control), whereas the individuals who carried out the bacterial cultures and assessed the results were kept blind to the allocation.
Interventions
Mothers in the study group were instructed to have skin-to-skin contact with their newborns in the NICU twice a day (morning and evening) for 60 minutes, for seven days (including weekends). Adherence to the intervention was verified daily and recorded on sheets. Skin-to-skin contact consisted of placing the infant wearing only a diaper in prone decubitus, upright against his mother's chest, between the breasts. The infant was restrained in position by a strap that tied him/her to his/her mother [18] and was covered with the mother’s clothes. NICU had its temperature maintained at 26 degrees Celsius.
All mothers underwent a routine hand washing procedure before entering the NICU. They did not have their chests scrubbed before skin-to-skin contact. The mother sat in a chair positioned by the side of the infants’ bed. Standing nurses transferred the babies to sitting mothers. A team member who accompanied the intervention monitored infant temperature, heart rate and oxygen saturation to ensure babies’ safety [19,20]. Both groups received routine nursing care such as nutrition, hygiene, bathing and diapering, organization of parents’ visit, breastfeeding and administration of drugs. Mothers were encouraged to touch, breast feed her baby and get him/her as soon as possible in her lap, under staff supervision. Fathers did not hold infants in skin-to-skin contact.
All mothers in the intervention group successfully completed 60 minutes of skin-to-skin contact for just one hour twice a day.
Outcomes
The primary endpoint for testing the efficacy of intervention was colonization status of newborns’ nostrils after 7 days of intervention (decolonization of the infants’ nostril from multi-drug resistant Staphylococcus). Birth weight (measured at birth using digital scales with 5 gram precision), gestational age (according the the last menstrual date), type of delivery (vaginal/cesarean section), sex (male/female), birth weight for gestational age (classified according to Alexander’s curve) [21], 5th min Apgar score and need for resuscitation (at delivery room) and antibiotic use (from birth to the end of data collection) were compared between groups.
Interim analysis and protocol of interruption
No interim analysis was performed. There was no need to interrupt the trial for safety reasons.
Data collection
The material for the first bacterial culture was collected at baseline from both mothers and their newborns by a nasal swab performed on the fourth, fifth or sixth day of hospitalization, by a lab technician using a cotton swab soaked in sterile saline solution that was introduced into the nasal cavity of newborns and their mothers. The results of the culture from the first collection of nasal swabs determined the eligibility of the dyads for randomization.
Decolonization was checked by a second swab collection seven days after the beginning of the intervention. The second culture was collected only from infants. No other site of culture collection was considered in addition to the nostrils. Collected materials were placed in Stuart transport medium and sent to the laboratory for seeding in 5% Agar sheep blood and Brain Heart Infusion (BHI) for 24 to 48 h at 35 °C. Cultures were considered to be positive when Staphylococcus was isolated by the catalase, coagulase and VitekbioMerieux® automated method. Antimicrobial susceptibility testing was performed by Kirby Bauer disc diffusion, following recommendations from the CLSI/2008. For the samples considered to be “methicillin-oxacillin resistant” the E-test was used for confirmation of sensitivity to vancomycin.
All newborns who remained colonized after the second nostril culture, performed 7 days after randomization, were decolonized according to the recommendations of the Hospital Infection Control Committee of each unit at the end of the 7 days.
Statistical analysis
Following CONSORT guidelines, we did not perform a statistical test comparing differences in baseline characteristics because of randomization.
For the analysis of primary outcome, we first applied the Mantel-Haenszel chi-square test for two proportions. In a second analysis we fitted a generalized linear model for the binomial family with a log link to control for possible confounding effects of small for gestational age birth, antibiotic use, need for resuscitation, sex and cesarean delivery. These variables were chosen based on the magnitude of differences in their distributions between the intervention and the control group. A p-value of less than 0.05 was considered statistically significant. All tests were two-tailed. To evaluate the clinical relevance of the outcome we calculated the Number Needed to Treat (NNT). Intention to treat analysis was not performed because there were no losses to follow-up.
Ethical considerations
The study was approved by the Ethics Research Committee of the University Hospital, Federal University of Maranhão, Brazil, under No. 33104-1504/07 on behalf of all three participating hospitals. Each hospital’s director gave institutional permission for the study. All newborns’ mothers read a Plain Language Statement, written in plain, simple language, explaining the purpose, methods, demands, risks and potential benefits of the research and signed a written informed consent form. This trial was registered with ClinicalTrials.gov under number NCT01498133.
Results
Mother-newborn dyads were recruited from April, 2008 through December, 2010. The flowchart in Figure 1 shows selection, allocation, intervention, monitoring and analysis of the patients enrolled in the study.
We assessed 247 newborns for eligibility. The eligible dyads (102) were distributed as follows: 25 at the University Hospital Unit, 175 at the Marly Sarney Maternity Hospital and 47 at the Benedito Leite Maternity Hospital. Among the 102 randomized patients, 83 infants had MRSA in the first culture and 19 had MRSE. Prevalence of MRSA/MRSE was 66.9%.
No participants were lost to treatment or follow-up after assignment to study groups and none of the newborns had changes in vital signs that required team interventions or stopping the procedure.
Baseline variables for the study groups are displayed in Table 1. The variables cesarean section, small for gestational age, need for resuscitation in the delivery room and antibiotics use were unbalanced between groups.
Table 1.
Perinatal characteristics of preterm infants
| Study group | Control group | |
|---|---|---|
| (N = 53) | (N = 49) | |
| Mean ± SD* | ||
| Birth weight | 1524.05 ± 157.37 | 1509.08 ± 172.84 |
| Gestational age | 32.0 ± 2.4 | 32.2 ± 2.3 |
| 5th minute Apgar score | 8.64 ± 1.0 | 8.62 ± 0.73 |
| Percentage (%) | ||
| Male sex | 49.1 | 50.9 |
| Born by cesarean delivery | 60.4 | 51,0 |
| Small for gestational age birth | 62.3 | 37.7 |
| Needed resuscitation in the delivery room | 43.1 | 34,7 |
| Antibiotics use | 52.8 | 76.1 |
*SD = standard deviation.
São Luís, Brazil, 2008-2010 (n = 102).
Outcomes and estimation
Decolonization rates were significantly different between groups, as illustrated in Table 2. Infants receiving skin-to-skin care were 2.35 times more likely to decolonize than the control group.
Table 2.
MRSA/MRSE decolonization in the infants’ nostrils in NICU in the intervention (skin-to-skin contact between mothers and newborns) and control groups
| Groups | Decolonization | No decolonization | RR* | 95% CI** | p-value*** |
|---|---|---|---|---|---|
| n (%) | n (%) | ||||
| Skin-to-skin contact | 28 (52.8 %) | 25 (47.2 %) | 2.35 | 1.32-4.20 | 0.002 |
| Control | 11 (22.4 %) | 38 (77.6 %) | |||
| Total | 39 (38.2 %) | 63 (61.8 %) |
São Luís, Brazil, 2008–2010.
*RR – risk ratio.
**CI – confidence interval.
***P-value estimated by the Mantel-Haenszel chi-square test.
Number Needed to Treat (NNT) was 4 (95% CI 2.2 – 9.4).
Even after adjustment for confounders skin-to-skin contact remained strongly associated with decolonization of newborns’ nostrils from MRSA/MRSE bacteria (Risk ratio = 2.30, 95% CI 1.30-4.06, p = 0.004) (Table 3).
Table 3.
Adjusted analysis of MRSA/MRSE decolonization of the nostrils of preterm infants admitted to the NICU (intervention vs. control group)
| Variables | Risk ratio* | 95% CI** | P-Value |
|---|---|---|---|
| Small for gestational age birth | 1.26 | 0.86-1.85 | 0.228 |
| Antibiotic use | 1.54 | 0.98-2.39 | 0.056 |
| Skin-to-skin contact | 2.30 | 1.30-4.06 | 0.004 |
| Need for resuscitation | 1.65 | 1.08-2.51 | 0.020 |
| Born by cesarean delivery | 0.81 | 0.57-1.15 | 0.245 |
São Luís, Brazil, 2008–2010 (n = 102).
*Estimated by a generalized linear model for the binomial family with a log link.
**CI – confidence interval.
It is worth noting that among those infants who decolonized from MRSA/MRSE, the same genera of bacteria that had grown in their mother’s baseline culture was identified in the infant’s second culture in 84.2% of cases (data not shown).
Discussion
More than half of the newborns who received skin-to-skin holding intervention from their mothers who were not colonized with MRSA/MRSE were decolonized at the end of the seven days of treatment, but the mechanism for decolonization is unclear.
Several researchers have suggested that the presence of nonpathogenic flora [8] or strains of Streptococcus [7] inhibit growth of MRSA, possibly by acting on or interfering with some stage of the colonization process. A similar mechanism, replacement of newborn’s multi-resistant flora with mothers’ non-pathogenic flora, may also be implicated.
A possible explanation for this finding is the phenomenon of bacterial interference, through which mothers’ sensitive bacteria replace newborn’s MRSA/MRSE. This possibly occurs through changes in bacterial microenvironment that include competition for nutrients and production of antagonistic substances by mother’s bacteria such as bacteriocins. Recent works, especially in the area of urology and otorhinolaryngology, have shown that it is possible to induce exchange of multiresistant bacterial flora by introducing certain strains of antibiotic-sensitive bacteria [11-13]. It is possible that such mechanism could also explain the effect of skin-to-skin contact in reducing the incidence and severity of infection episodes in preterm infants, as observed in several studies [15,16].
In our study we found that children who decolonized from MRSA / MRSE had the same genera of bacteria of his mother's culture in 84.2% of cultures performed seven days after the beggining of the intervention. This increases the likelihood that replacement of infant’s multiresistant bacteria had occurred with their mother’s non-MRSA/MRSE bacteria.
The intensity of the effect of decolonization was demonstrated by the number needed to treat (NNT). Just four newborns had to undergo skin-to-skin contact for one decolonization to be observed, a potentially huge effect.
Decolonization of the control group could have been due to other factors present in the NICU. It is plausible that this fact occurred spontaneously or was influenced by other types of babies’ manipulation during routine care in the NICU. Kohler et al. describes spontaneous clearance rate (MRSA decolonization) of 22% [22]. Decolonization of 50% of infants who underwent skin-to-skin contact is of great importance since other methods of decolonization, such as the use of topical antibiotics and bathing with chlorhexidine, pose risk for premature babies, as shown by Nelson et al. in 2014 [4].
Limitations
The impossibility of blinding mothers and researchers to the intervention could have led to differences in neonatal care between groups. However, the individuals who carried out the bacterial cultures and assessed the results were kept blind to the allocation. These differences are unlikely to have provoked changes in the results of bacterial cultures of nasal mucosa.
Colonization with non-pathogenic bacteria could also have been mediated through the individuals who moved the infant from the NICU bed to the skin-to-skin contact position with their mothers. However, contact time between these personnel and the newborns was short. In addition, all newborns had similar manipulation. Mothers and babies had not had any previous experience with skin-to-skin contact before the study, a fact that reduces the likelihood that mothers in the control group had performed skin-to-skin-contact during the study. Although data on breastfeeding have not been collected, breastfeeding routine was similar in both groups. Although colonization of the newborns’ nostrils in the intervention group could have occurred by any skin-to-skin contact, most skin-to-skin contact was provided by the kangaroo position.
No site of culture collection other than the nostrils was used in this work. While PCR for mecA is considered the gold standard assay for the detection of MRSA, the Vitek automated method used in our work is also reliable to detect MRSA, with sensitivity ranging from 90% to 99% and specificity close to 100% [23,24]. It is known that nasal swabs could be not so sensitive in assessing CA-MRSA colonization and that a negative test for nasal colonization does not rule out MRSA [25]. It is also known that colonization and/or culture yield can result in intermittently positive samples [26].
Conclusions
Replacement of non-MRSA/MRSE bacteria from mothers to newborns through skin-to-skin contact could have occurred to explain a more than two-fold higher decolonization rate in the intervention group compared to the control group. The phenomenon of bacterial interference might be a possible mechanism explaining this finding.
The current methods of controlling bacterial outbreaks in the NICU are not effective in preventing endemic multiresistant Staphylococcus infection and can increase bacterial resistance [2,4,27,28]. The findings of this study might be a possible alternative to the decolonization of MRSA/MRSE from the infants’ nostrils because the procedure proved to be safe and effective and the number needed to decolonize one patient (NNT = 4.0) is superior to other methods of decolonization [28]. However, it is necessary to ensure that mothers eligible to practice skin-to-skin position with their babies are not carriers of MRSA/MRSE, since there is evidence in the literature that points to the possibility of transmission of this pathogen from mother to newborn [8,9].
Neonatal mortality by nosocomial infection remains one of the greatest challenges of public health [29-31]. Skin-to-skin contact between mothers and their newborns might be a safe and cost-effective strategy of biological control to promote decolonization of multiresistant bacteria and a possible reduction of nosocomial infections in the NICU.
Acknowledgements
This research was funded by the Brazilian Research Council (CNPq in the Portuguese acronym) and the Maranhão State Research Foundation (FAPEMA in the Portuguese acronym).
Footnotes
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
FLF conceived the study. SS and IF collected the data. FLF, ZL and VS supervised data collection. FLF performed the statistical analysis. AS and MB helped in the statistical analysis. All authors collaborated in drafting the manuscript and contributed to its intellectual content. All authors read and approved the final version of the manuscript.
Contributor Information
Fernando Lamy Filho, Email: lamyfilho@gmail.com.
Sílvia Helena Cavalcante de Sousa, Email: shcsouza@gmail.com.
Isolina Januária Sousa Freitas, Email: isolina@msn.com.
Zeni Carvalho Lamy, Email: zenilamy@gmail.com.
Vanda Maria Ferreira Simões, Email: vandamfsimoes@gmail.com.
Antônio Augusto Moura da Silva, Email: aamouradasilva@gmail.com.
Marco Antônio Barbieri, Email: mabarbieri@fmrp.usp.br.
References
- 1.Huang YC, Chou YH, Su LH, Lien RI, Lin TY. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics. 2006;118:469–74. doi: 10.1542/peds.2006-0254. [DOI] [PubMed] [Google Scholar]
- 2.Humpheys H. Can we do better in preventing and controlling methicillin-resistant Staphylococcus aureus (MRSA) in the intensive care unit (ICU)? Eur J Clin Microbiol. 2008;27:409–13. doi: 10.1007/s10096-008-0469-7. [DOI] [PubMed] [Google Scholar]
- 3.Clements A, Halton K, Graves N, Pettitt A, Morton A, Looke D, et al. Overcrowding and understaffing in modern health-care systems: key determinants in methicillin-resistant Staphylococcus aureus transmission. Lancet Infect Dis. 2008;8:427–34. doi: 10.1016/S1473-3099(08)70151-8. [DOI] [PubMed] [Google Scholar]
- 4.Nelson MU, Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. One size does not fit all: why universal decolonization strategies to prevent methicillin-resistant Staphylococcus aureus colonization and infection in adult intensive care units may be inappropriate for neonatal intensive care units. J Perinatol. 2014;34:653–5. doi: 10.1038/jp.2014.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gerber SI1, Jones RC, Scott MV, Price JS, Dworkin MS, Filippell MB, Rearick T, Pur SL, McAuley JB, Lavin MA, Welbel SF, Garcia-Houchins S, Bova JL, Weber SG, Arnow PM, Englund JA, Gavin PJ, Fisher AG, Thomson RB, Vescio T, Chou T, Johnson DC, Fry MB, Molloy AH, Bardowski L, Noskin GA. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol. 2006;27:139–145. [DOI] [PubMed]
- 6.McConeghy KM, Mikolich DJ, LaPlante KL. Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy. 2009;29:263–80. doi: 10.1592/phco.29.3.263. [DOI] [PubMed] [Google Scholar]
- 7.Uehara Y, Kikuchi K, Nakamura T, Nakama H, Agematsu K, Kawakami Y, et al. Inhibition of methicillin-resistant Staphylococcus aureus colonization of oral cavities in newborns by Viridans group Streptococci. Clin Infect Dis. 2001;32:1399–407. doi: 10.1086/320147. [DOI] [PubMed] [Google Scholar]
- 8.Shimizu A, Shimizu K, Nakamura T. Non-pathogenic bacterial flora may inhibit colonization by methicillin-resistant Staphylococcus aureus in extremely low birth weight infants. Neonatology. 2008;93:158–61. doi: 10.1159/000108413. [DOI] [PubMed] [Google Scholar]
- 9.Kawada M, Okuzumi K, Hitomi S, Sugishita C. Transmission of Staphylococcus aureus between healthy, lactating mothers and their infants by breastfeeding. J Hum Lact. 2003;19:411–17. doi: 10.1177/0890334403257799. [DOI] [PubMed] [Google Scholar]
- 10.Sakaki H, Nishioka M, Kanda K, Takahashi Y. An investigation of the risk factors for infection with methicillin-resistant Staphylococcus aureus among patients in the neonatal intensive care unit. Am J Infect Control. 2009;37:580–6. doi: 10.1016/j.ajic.2009.02.008. [DOI] [PubMed] [Google Scholar]
- 11.Crow CC, Sanders WE., Jr Bacterial interference. Role of the normal throat flora in prevention of colonization by group A Streptococcus. J Inf Dis. 1973;128:527–32. doi: 10.1093/infdis/128.4.527. [DOI] [PubMed] [Google Scholar]
- 12.Murray PR, Rosenblatt JE. Bacterial interference by orofaryngeal and clinic isolates of anaerobic bacteria. J Infect Dis. 1976;134:281–5. doi: 10.1093/infdis/134.3.281. [DOI] [PubMed] [Google Scholar]
- 13.Darouiche RO, Donovan WH, Del Terzo M, Thornby JI, Rudy DC, Hull RA. Pilot trial of bacterial interference for preventing urinary tract infection. Urology. 2001;58:339–44. doi: 10.1016/S0090-4295(01)01271-7. [DOI] [PubMed] [Google Scholar]
- 14.Brooke I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Head & Neck Surg. 2005;133:139–46. doi: 10.1016/j.otohns.2005.03.012. [DOI] [PubMed] [Google Scholar]
- 15.Lawn JE, Mwansa-Kambafwile J, Horta BL, Barros FC, Cousens S. ‘Kangaroo mother care’ to prevent neonatal deaths due to preterm birth complications. Int J Epidemiol. 2010;39(Suppl 1):144–54. doi: 10.1093/ije/dyq031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Conde-Agudelo A, Belizán JM, Diaz-Rossello J. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database Syst Rev. 2011;16(3) doi: 10.1002/14651858.CD002771.pub2. [DOI] [PubMed] [Google Scholar]
- 17.Jefferies AL. Kangaroo care for the preterm infant and family. Canadian Paediatric Society, Fetus and Newborn Committee. Paediatr Child Health. 2012;17(3):141–6. doi: 10.1093/pch/17.3.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.BRASIL, Ministério da Saúde, Secretaria de Atenção à Saúde; Departamento de Ações Programáticas Estratégicas . Atenção humanizada ao recém-nascido de baixo peso: Método Canguru. Brasília: Ministério da Saúde; 2011. [Google Scholar]
- 19.Ludington-Hoe SM, Ferreira C, Swinth J, Ceccardi JJ. Safe Criteria and Procedure for Kangaroo Care With Preterm Infants intubated. J Obstet Gynecol Neonatal Nurs. 2003;32:579–88. doi: 10.1177/0884217503257618. [DOI] [PubMed] [Google Scholar]
- 20.Mori R, Khanna R, Pledge D, Nakayama T. Meta-analysis of physiological effects of skin-to-skin contact for mothers and newborns. Pediatr Int. 2010;52:161–70. doi: 10.1111/j.1442-200X.2009.02909.x. [DOI] [PubMed] [Google Scholar]
- 21.Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol. 1996;87:163–8. doi: 10.1016/0029-7844(95)00386-X. [DOI] [PubMed] [Google Scholar]
- 22.Kohler P, Bregenzer-Witteck A, Rettenmund G, Otterbech S, Schlegel M. MRSA decolonization: success rate, risk factors for failure and optimal duration of follow-up. Infection. 2013;41:33–40. doi: 10.1007/s15010-012-0290-1. [DOI] [PubMed] [Google Scholar]
- 23.Yamazumi T, Marshall SA, Wilke WW, Diekema DJ, Pfaller MA, Jones RN. Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus. J Clin Microbiol. 2001;39:53–6. doi: 10.1128/JCM.39.1.53-56.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Sakoulas G, Gold HS, Venkataraman L, DeGirolami PC, Eliopoulos GM, Qian Q. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J Clin Microbiol. 2001;39:3946–51. doi: 10.1128/JCM.39.11.3946-3951.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Robicsek A, Suseno M, Beaumont JL, Thomson RB, Jr, Peterson LR. Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling. J Clin Microbiol. 2008;46:588–92. doi: 10.1128/JCM.01746-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Stone ND, Lewis DR, Lowery HK, Darrow LA, Kroll CM, Gaynes RP, et al. Importance of bacterial burden among methicillin-resistant Staphylococcus aureus carriers in a long-term care facility. Infect Control Hosp Epidemiol. 2008;29:143–8. doi: 10.1086/526437. [DOI] [PubMed] [Google Scholar]
- 27.Huang YC, Chao AS, Chang SD, Chen YJ, Peng MT, Sung JH, et al. Association of Staphylococcus aureus colonization in parturient mothers and their babies. Pediatr Infect Dis J. 2009;28:742–4. doi: 10.1097/INF.0b013e31819c132a. [DOI] [PubMed] [Google Scholar]
- 28.Gregory LM, Eichenwald EC, Puopolo KM. Seven-year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit. Pediatrics. 2009;123:790–6. doi: 10.1542/peds.2008-1526. [DOI] [PubMed] [Google Scholar]
- 29.Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1999;43:1412–16. doi: 10.1128/aac.43.6.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Goetghebeur M, Landry PA, Han D, Vicente C. Methicillin-resistant Staphylococcus aureus: a public health issue with economic consequences. Can J Infect Dis Med Microbiol. 2007;18:27–34. doi: 10.1155/2007/253947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Song X, Perencevich E, Campos J, Short BL, Singh N. Clinical and economic impact of methicillin-resistant Staphylococcus aureus colonization or infection in neonates on intensive care units. Infect Control Hosp Epidemiol. 2010;3:177–82. doi: 10.1086/649797. [DOI] [PubMed] [Google Scholar]